Synthesis, antiinflammatory and antimicrobial activity of 6-(1H-benzimidazol-2-yl)-5-methyl-4-(alkylthio)thieno[2,3-d]pyrimidines
DOI:
https://doi.org/10.24959/nphj.16.2112Keywords:
thiophene, pyrimidine, mercaptans, antiinflammatory, antibcterialsAbstract
An effective method for synthesis of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidine-4(3H)-thione starting from the corresponding 4-oxo analog has been developed. For the chemical diversity enlargement the alkylation of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidine-4(3H)-thione with benzyl chloroides, chloroacetamides and 3-aryl-5-(chloromethyl)-1,2,4-oxadiazoles, which resulted in the series of 6-(1H-benzimidazol-2-yl)-5-methyl-4-(alkylthio)thieno[2,3-d]pyrimidines has been carried out. For the compounds obtained the screening of antimicrobial activity by the "agar well" diffusion method and antiinflammatory activity using the carrageenan rat paw edema model were performed. The results of the tests showed that alkylation of the sulphur atom at position 4 of thieno[2,3-d]pyrimidine improves the antimicrobial properties. Most of the 6-(1H-benzimidazol-2-yl)-5-methyl-4-(alkylthio)thieno[2,3-d]pyrimidines were active against the Candida albicans fungi strain. The compound containing the chlorine atom in the phenyl radical of thioacetamide fragment at position 4 of thieno[2,3-d]pyrimidine were found to be active against Staphylococcus aureus, Escherichia coli and Bacillus subtilis. After the treatment of rats with 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidine-4(3H)-one, 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidine-4(3H)-thione and 2-{[6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4-yl]thio}-N-phenylacetamide (dosages 1, 10 and 50 mg/kg) no statistically significant and dose-dependent reduction of the edema was observed versus the control pathology. The anti-inflammatory activity of the tested compounds was about 20%, which was 2-2,5 times less than the activity of the reference drug (diclofenac sodium).References
Власов С. В., Заремба О. В., Коваленко С. М. та ін. // Журнал орг. фарм. хім. – 2011. –Т. 9, №4. – С. 24 – 30.
Власов С. В., Коваленко С. М., Федосов А. І. та ін. // Журнал орг. фарм. хім. – 2011. – Т. 9, №3. С. 51 – 55.
Власов С. В., Коваленко С. М., Черних В. П. // Журнал орг. фарм. хім. – 2013. – Т.11, №2. – С. 41 – 46.
Доклінічні дослідження лікарських засобів. Методичні рекомендації// За ред. О.В. Стефанова. – Київ. – 2001. – 528 с.
Некрасова Л.С., Свита В.М., Глушкевич Т.Г. та ін. Методичні вказівки "Визначення чутливості мікроорганізмів до антибактеріальних препаратів "— Київ, 2007. — 79 с.
American Society for Microbiology. Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology: Washington. 2005. – P. 236.
Ansari K.F., Lal C. // Eur. J.Med. Chem. – 2009. – Vol. 44, No. 5. – P. 2294-2299.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Document M100-S22, Vol. 32, No. 3, CLSI, Wayne, PA, January, 2012.
Di Rosa M., Giround J.P., Williughby D.A. // J. Pathol. – 1971. – Vol. 104. - № 1. – P. 15-29.
Evans D., Hicks T. A., Williamson W. R. N. et al. // Eur. J. Med. Chem. – 1996. – Vol. 31, № 7-8. – P. 635-642.
Grinev A.N, Kaplina N.V. // Chem. of Heterocycl. Compnd. — 1985. — Vol. 21, № 7. – P. 767 - 770.
Achar K.C.S., Hosamani K.M., Seetharamareddy H.R.// Eur. J. Med. Chem. – 2010. – Vol. 45, №5. – P. 2048-2054.
Kotaiah Y., Harikrishna N., Nagaraju K., Venkata Rao C. // Eur. J. Med. Chem. – 2012. – Vol. 58. – P. 340- 345.
Kumar B.V.S., Vaidya S.D., Kumar R.V. et al. // Eur. J. Med. Chem., 2006. – Vol. 41, №5. – P. 599–604.
Leonard J.T., Jeyaseeli L., Kumar M., Sivakumar R. // Asian J. Chem. – 2006. – Vol. 18, №2. – P. 1104-1108.
Mariappan G., Bhuyan N. R., Kumar P. // Indian Journal of Chemistry -Section B. – 2011. – Vol.50B, №9. – P. 1216-1219.
Mavrova A.T., Anichina K.K., Vuchev D.I. et al. // Eur. J. Med. Chem. – 2006. –Vol.41, №12. – P. 1412-1420.
Pat. US 20070208040 (2007); Chem. Abstr., 147, 344106 (2007).
Pat. US 20130102601 (2013); Chem. Abstr., 158, 620878 (2013).
Pat. US 20130123231 (2013); Chem. Abstr., 158, 711376 (2013).
Sravanthi M., Nagaraju N., Manikanta K., Mogalabi Sk. et al. // J. Chem. Pharm. Res. – 2012. – Vol. 4, №8. P. 3832-3836.
Vlasov S. V., Kovalenko S. M., Chernykh V. P., Krolenko K.Yu. // J. Chem. Pharm. Res. –2014. – Vol. 6, № 6. – P. 22 – 27.
Vlasov S.V., Kovalenko S.M., Chernykh V.P., Krolenko K.Yu. // J. Org. Pharm. Chem.– 2015. – Vol. 13, №2. – P. 30-34.
Yadav S., Kumar P., Clercq E.D. et al. // Eur. J. Med. Chem. – 2010. – Vol. 45, № 12. – P. 5985-5997.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).